Guide: How to conduct market research for rare diseases

A best practice guide

The opportunity for rare diseases has become significant as manufacturers of orphan drugs are being awarded longer market exclusivity, reduced regulatory fees and tax incentives. However, commercialization can be challenging, because of the size of patient populations, the cost of drugs, and the difficulty in diagnosing conditions. A successful product launch relies on insightful market intelligence to leverage the opportunity.

However, conducting effective research for rare diseases can be challenging. Drawing upon our considerable experience of managing both small and large scale studies across a number of different diseases, we have created a guide outlining the key steps required to implement an effective market research programme. The guide covers: 

- Sampling and recruitment
- Ethical considerations and constraints
- Suitable methodologies
- Impactful analysis and outputs 

 

Rare diseases guide

Request the guide

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here